Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway-Reference-Cited by-同舟云学术

Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway

Published:2021-11 Issue: Volume: Page:
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Lei Qian,Yu Zhimin,Li Hang,Cheng Jun,Wang Yanggan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference40 articles.

1. New and Emerging Therapies for Pulmonary Arterial Hypertension;Spiekerkoetter;Annu Rev Med,2019

2. The Diagnostic Challenge of Group 2 Pulmonary Hypertension;Naeije;Prog Cardiovasc Dis,2016

3. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension;Do.e;Circ J,2009

4. Pulmonary hypertension due to left heart disease;Guazzi;Circulation,2012

5. Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options;Rosenkranz;Clin Res Cardiol,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential safety implications of fatty acid-binding protein inhibition;Toxicology and Applied Pharmacology;2024-10

2. The Identification of Key Genes and Biological Pathways in Cardiac Arrest by Integrated Bioinformatics and Next Generation Sequencing Data Analysis;2024-08-19

3. Pulmonary hypertension associated to left heart disease: Phenotypes and treatment;European Journal of Internal Medicine;2024-08

4. Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice;Scientific Reports;2024-06-03

5. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08